Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of the Egyptian National Cancer Institute is Scopus-indexed (Q3, CiteScore 3.2), WoS ESCI, DOAJ. Published by Springer Science and Business Media Deutschland GmbH.
Checked against the index lists dated .
ISSN 1110-0362Verify ISSN ↗2589-0409Verify ISSN ↗
Publisher: Springer Science and Business Media Deutschland GmbH
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 253 / 428 | 41st | Q3 |
| Cancer Research | 174 / 233 | 25th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present (also 2005–2009), best quartile Q3, CiteScore 3.2.
Journal of the Egyptian National Cancer Institute is Q3 in Oncology (rank 253 of 428) and Q3 in Cancer Research (rank 174 of 233), by CiteScore 2025.
Journal of the Egyptian National Cancer Institute is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.2, which places it in quartile Q3 at the 41st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.551, quartile Q3, with an H-index of 33.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Journal of the Egyptian National Cancer Institute is published by Springer Science and Business Media Deutschland GmbH. Its print ISSN is 1110-0362 and its online ISSN is 2589-0409.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Journal of the Egyptian National Cancer Institute has an h-index of 36 and a 2-year mean of 2.12 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q3. On 2-year citations it ranks #186 of 424 Scopus journals in Oncology.
Journal of the Egyptian National Cancer Institute published 81 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from India (19.8%), Egypt (18.8%) and China (13.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.